AGMAT
Basic information
Region (hg38): 1:15571699-15585051
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the AGMAT gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 25 | 27 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 25 | 2 | 2 |
Variants in AGMAT
This is a list of pathogenic ClinVar variants found in the AGMAT region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-15573657-G-A | Benign (Oct 19, 2017) | |||
1-15573706-G-A | not specified | Uncertain significance (Aug 17, 2021) | ||
1-15574762-A-G | not specified | Likely benign (Jun 22, 2021) | ||
1-15574771-G-T | not specified | Uncertain significance (Apr 26, 2023) | ||
1-15574789-A-G | not specified | Uncertain significance (Oct 26, 2022) | ||
1-15574798-C-T | not specified | Uncertain significance (Mar 12, 2024) | ||
1-15577783-C-G | not specified | Uncertain significance (Jun 18, 2021) | ||
1-15577858-G-A | not specified | Uncertain significance (Jul 26, 2022) | ||
1-15578893-G-A | Benign (May 30, 2017) | |||
1-15578905-C-T | not specified | Uncertain significance (Mar 16, 2022) | ||
1-15578926-C-T | not specified | Uncertain significance (May 26, 2024) | ||
1-15578959-C-T | not specified | Uncertain significance (Feb 27, 2024) | ||
1-15578984-G-T | not specified | Uncertain significance (Dec 28, 2022) | ||
1-15578987-T-G | not specified | Uncertain significance (Nov 01, 2022) | ||
1-15579005-C-T | not specified | Uncertain significance (Aug 02, 2021) | ||
1-15579016-G-A | not specified | Likely benign (May 08, 2024) | ||
1-15580137-C-T | Moyamoya angiopathy | Likely pathogenic (-) | ||
1-15583262-C-T | not specified | Uncertain significance (Oct 20, 2023) | ||
1-15583327-A-G | not specified | Uncertain significance (Feb 16, 2023) | ||
1-15583378-A-G | not specified | Uncertain significance (May 25, 2022) | ||
1-15583384-C-T | not specified | Uncertain significance (Aug 28, 2023) | ||
1-15583391-C-T | not specified | Uncertain significance (Dec 06, 2022) | ||
1-15584748-C-A | not specified | Uncertain significance (Apr 07, 2023) | ||
1-15584773-C-A | not specified | Uncertain significance (Sep 25, 2023) | ||
1-15584793-T-C | not specified | Uncertain significance (Nov 06, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
AGMAT | protein_coding | protein_coding | ENST00000375826 | 7 | 12758 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.24e-7 | 0.207 | 125638 | 0 | 110 | 125748 | 0.000437 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.805 | 162 | 194 | 0.837 | 0.0000117 | 2213 |
Missense in Polyphen | 75 | 91.425 | 0.82035 | 962 | ||
Synonymous | 0.669 | 68 | 75.4 | 0.902 | 0.00000444 | 761 |
Loss of Function | 0.200 | 11 | 11.7 | 0.937 | 5.39e-7 | 147 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000572 | 0.000572 |
Ashkenazi Jewish | 0.0000993 | 0.0000992 |
East Asian | 0.000163 | 0.000163 |
Finnish | 0.000278 | 0.000277 |
European (Non-Finnish) | 0.000646 | 0.000642 |
Middle Eastern | 0.000163 | 0.000163 |
South Asian | 0.000425 | 0.000425 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Pathway
- Arginine and proline metabolism - Homo sapiens (human);putrescine biosynthesis II;Urea cycle and metabolism of arginine, proline, glutamate, aspartate and asparagine
(Consensus)
Recessive Scores
- pRec
- 0.213
Intolerance Scores
- loftool
- 0.309
- rvis_EVS
- 0.11
- rvis_percentile_EVS
- 61.91
Haploinsufficiency Scores
- pHI
- 0.103
- hipred
- N
- hipred_score
- 0.239
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.946
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Agmat
- Phenotype
Gene ontology
- Biological process
- spermidine biosynthetic process;putrescine biosynthetic process from arginine;agmatine biosynthetic process
- Cellular component
- mitochondrion
- Molecular function
- agmatinase activity;metal ion binding